Search

everythinglearnresearchcommunity

for

Search:↓

A substance called prostaglandin D2 is linked to stopping hair growth in men with common baldness.

Setipiprant may reduce inflammation by blocking an enzyme called aldose reductase.

Blocking Prostaglandin D₂ (PGD₂) could help treat hair loss.

Targeting CXXC5 and GSK-3β may help treat male pattern baldness.

Blocking Prostaglandin D₂ may help treat hair loss.

Blocking Oncostatin M's role in the JAK-STAT pathway can stimulate hair growth in mice.

Double-stranded RNA activates a pathway that causes a skin protein to be expressed in the wrong place.

Early exposure to germs may protect against autoimmune diseases, lack of sex increases alcohol preference in fruit flies, a potential baldness treatment could involve blocking a specific receptor, skin memory cells help prevent re-infection, high-fat diets can affect brain cells related to weight, and the link between social status, stress, and heart disease in primates is unclear.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

Different human hair follicle stem cells grow at different rates and respond differently to a baldness-related compound.

The research explains how a human enzyme binds and processes its substrate, which could relate to its role in biological functions and hair loss.

Prostaglandin D2 increases testosterone production in skin cells through a process involving reactive oxygen species, and antioxidants may help treat hair loss.

Higher DHT in male baldness may protect against prostate cancer.

Prostaglandins may contribute to male hair loss; targeting them could help treat it.

Use antiandrogens and other treatments for hair loss.

Lithocholic acid helps hair growth and regeneration in alopecia by activating vitamin D receptors.

Blocking COX, especially COX-2, in the skin can reduce inflammation and pain and may help prevent skin cancer.

Hair loss involves immune responses, inflammation, and disrupted signaling pathways.

New hair loss treatments may include topical medications, injections, and improved transplant methods.

Lipocalin-Type Prostaglandin D2 Synthase (L-PGDS) is a protein that plays many roles in the body, including sleep regulation, pain management, food intake, and protection against harmful substances. It also affects fat metabolism, glucose intolerance, cell maturation, and is involved in various diseases like diabetes, cancer, and arthritis. It can influence sex organ development and embryonic cell differentiation, and its levels can be used as a diagnostic marker for certain conditions.

Prostaglandins and the enzyme AKR1C3 could play a role in skin cancer and hair loss, and further research is needed to understand these mechanisms.

Prostaglandin D2 increases testosterone production in skin cells through a process involving reactive oxygen species, which could be a new target for treating hair loss and other skin conditions driven by testosterone.

A substance called compound-1 could help increase hair growth by maintaining prostaglandin levels in hair follicles.

Leptin-deficient mice, used as a model for Type 2 Diabetes, have delayed wound healing due to impaired contraction and other dysfunctional cellular responses.

People with androgenetic alopecia have different lipid levels in their blood, which vary between men and women, and may be linked to a higher risk of metabolic syndrome.

L-PGDS has specific binding sites for its functions and could help in drug delivery system design.

Using a gel called Diclofenac can potentially cause hair to grow back in bald spots in older men.

Breast cancer hormone therapy can cause hair loss, which can be treated with daily applications of specific topical solutions like minoxidil and hydrocortisone butyrate.

Using lidocaine before keloid injections makes the treatment more comfortable for patients.

Gypenosides from Gynostemma pentaphyllum were found to have anti-aging effects, increasing skin collagen and reducing wrinkles.